$MASH token has gathered huge attention in its ongoing phase 3 of pre-sale, till press time the total raised amount by the ...

Among patients with baseline and week 96 biopsies, 39 percent of participants treated with 50mg efruxifermin showed cirrhosis reversal with no worsening of MASH compared to 15 percent from placebo ...

A study shows that patients with obesity and fatty liver-related cirrhosis ... Obesity and diabetes are the leading causes of metabolic dysfunction-associated steatohepatitis (MASH), which is the most ...

The first trailer for Delicious, the directorial debut from German filmmaker Nele Mueller-Stöfen, is here – and we're getting ...

Bariatric surgery significantly reduced long-term risk for decompensation and adverse outcomes in patients with obesity and ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

On Monday, at 10:23 a.m. GMT-5, Akero Therapeutics ( AKRO, Financials) saw its stock soar by 106.63%, closing at $54.10, ...

Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study repor ...

Cory Branan almost prefers when fans who haven't heard of him come in knowing absolutely nothing about his art. "I like to ...